1.Clinical Efficacy of the Transradial Approach in Percutaneous Intervention for a Malfunctioning Arteriovenous Fistula
Hyun Young CHOI ; Gyoo-Sik JUNG ; Hee KANG ; Ye Na KIM ; Hyung Hwan MOON ; Jong Hyouk YUN
Journal of the Korean Radiological Society 2022;83(3):658-668
Purpose:
To evaluate the effectiveness of the transradial artery approach (TRA) for treating malfunctioning arteriovenous fistulas (AVFs) in patients on hemodialysis.
Materials and Methods:
A retrospective analysis was conducted in this single-center study of TRA endovascular procedures in 73 patients (43 male and 30 female; mean age of 67.4 years (range, 42–92 years) with malfunctioning AVFs, between January 2008 and April 2019. Patients’ baseline and lesion characteristics, technical and clinical success, and complications were evaluated, and functional patency was analyzed using the Kaplan-Meier method.
Results:
Radial artery approaches were successful in all patients. Angioplasty performed using the TRA achieved technical and clinical success rates of 98.6%(72/73) and 91.7%(67/73), respectively. The median primary patency time was 18.8 ± 15.9 months. The primary functional patency rates at 3, 6, and 12 months were 82.1%, 68.6%, and 63.9%, respectively. There were no major complications or adverse events, such as hand ischemia, related to the radial artery approach.
Conclusion
In selected cases, the TRA can be used complementary to the transvenous approach to treat malfunctioning AVFs.
2.Clinical Outcomes of Endoscopic Resection for Low-Grade Dysplasia and High-Grade Dysplasia on Gastric Pretreatment Biopsy: Korea ESD Study Group
Jung Won JEON ; Soo Jin KIM ; Jae Young JANG ; Sun-Moon KIM ; Chul-Hyun LIM ; Jae Myung PARK ; Su Jin HONG ; Chan Gyoo KIM ; Seong Woo JEON ; Si Hyung LEE ; Jae Kyu SUNG ; Gwang Ho BAIK
Gut and Liver 2021;15(2):225-231
Background/Aims:
Some cases of gastric low-grade dysplasia (LGD) and high-grade dysplasia (HGD) on forceps biopsy (FB) are diagnosed as gastric cancer (GC) after endoscopic resection (ER). This study aims to evaluate the clinical outcomes of ER for gastric LGD and HGD on pretreatment FB and to identify the factors that predict pathologic upstaging to GC.
Methods:
Patients who underwent ER for LGD and HGD on pretreatment FB from March 2005 to February 2018 in 14 hospitals in South Korea were enrolled, and the patients’ medical records were reviewed retrospectively.
Results:
This study included 2,150 cases of LGD and 1,534 cases of HGD diagnosed by pretreatment FB. In total, 589 of 2,150 LGDs (27.4%) were diagnosed as GC after ER. Helicobacter pylori infection, smoking history, tumor location in the lower third of the stomach, tumor size >10 mm, depressed lesion, and ulceration significantly predicted GC. A total of 1,115 out of 1,534 HGDs (72.7%) were diagnosed with GC after ER. Previous history of GC, H. pylori infection, smoking history, tumor location in the lower third of the stomach, tumor size >10 mm, depressed lesion, and ulceration were significantly associated with GC. As the number of risk factors predicting GC increased in both LGD and HGD on pretreatment FB, the rate of upstaging to GC after ER increased.
Conclusions
A substantial proportion of LGDs and HGDs on pretreatment FB were diagnosed as GC after ER. Accurate ER procedures such as endoscopic submucosal dissection should be recommended in cases of LGD and HGD with factors predicting pathologic upstaging to GC.
3.Bleeding after Endoscopic Resection in Patients with End-Stage Renal Disease on Dialysis: A Multicenter Propensity Score-Matched Analysis
In Kyung YOO ; Chan Gyoo KIM ; Young Ju SUH ; Younkyung OH ; Gwang Ho BAIK ; Sun Moon KIM ; Young Dae KIM ; Chul-Hyun LIM ; Jung Won JEON ; Su Jin HONG ; Byoung Wook BANG ; Joon Sung KIM ; Jun-Won CHUNG
Clinical Endoscopy 2020;53(4):452-457
Background/Aims:
Frequent bleeding after endoscopic resection (ER) has been reported in patients with end-stage renal disease (ESRD). We aimed to evaluate the association and clinical significance of bleeding with ER in ESRD patients on dialysis.
Methods:
Between February 2008 and December 2018, 7,571 patients, including 47 ESRD patients on dialysis who underwent ER for gastric neoplasia, were enrolled. A total of 47 ESRDpatients on dialysis were propensity score-matched 1:10 to 470 non-ESRD patients, to adjust for between-group differences in variables such as age, sex, comorbidities, anticoagulation use, tumor characteristics, and ER method. Matching was performed using an optimal matching algorithm. For the matched data, clustered comparisons were performed using the generalized estimating equation method. Medical records were retrospectively reviewed. Frequency and outcomes of post-ER bleeding were evaluated.
Results:
Bleeding was more frequent in the ESRD with dialysis group than in the non-ESRD group. ESRD with dialysis conferred a significant risk of post-ER bleeding (odds ratio, 6.1; 95% confidence interval, 2.7–13.6; p<0.0001). All post-ER bleeding events were controlled using endoscopic hemostasis except in 1 non-ESRD case that needed surgery.
Conclusions
ESRD with dialysis confers a bleeding risk after ER. However, all bleeding events could be managed endoscopically without sequelae. Concern about bleeding should not stop endoscopists from performing ER in ESRD patients on dialysis.
4.Renal Tubular Acidosis in Patients with Primary Sjögren's Syndrome.
Su Woong JUNG ; Eun Ji PARK ; Jin Sug KIM ; Tae Won LEE ; Chun Gyoo IHM ; Sang Ho LEE ; Ju Young MOON ; Yang Gyun KIM ; Kyung Hwan JEONG
Electrolytes & Blood Pressure 2017;15(1):17-22
Primary Sjögren's syndrome (pSS) is characterized by lymphocytic infiltration of the exocrine glands resulting in decreased saliva and tear production. It uncommonly involves the kidneys in various forms, including tubulointerstitial nephritis, renal tubular acidosis, Fanconi syndrome, and rarely glomerulonephritis. Its clinical symptoms include muscle weakness, periodic paralysis, and bone pain due to metabolic acidosis and electrolyte imbalance. Herein, we describe the cases of two women with pSS whose presenting symptoms involve the kidneys. They had hypokalemia and normal anion gap metabolic acidosis due to distal renal tubular acidosis and positive anti-SS-A and anti-SS-B autoantibodies. Since one of them experienced femoral fracture due to osteomalacia secondary to renal tubular acidosis, an earlier diagnosis of pSS is important in preventing serious complications.
Acid-Base Equilibrium
;
Acidosis
;
Acidosis, Renal Tubular*
;
Autoantibodies
;
Diagnosis
;
Exocrine Glands
;
Fanconi Syndrome
;
Female
;
Femoral Fractures
;
Glomerulonephritis
;
Humans
;
Hypokalemia
;
Kidney
;
Muscle Weakness
;
Nephritis, Interstitial
;
Osteomalacia
;
Paralysis
;
Saliva
;
Tears
5.Phlegmonous Gastritis with Early Gastric Cancer.
Kyung Hee KIM ; Chan Gyoo KIM ; Young Woo KIM ; Hae MOON ; Jee Eun CHOI ; Soo Jeong CHO ; Jong Yeul LEE ; Il Ju CHOI
Journal of Gastric Cancer 2016;16(3):195-199
Phlegmonous gastritis is a rare and rapidly progressive bacterial infection of the stomach wall, with a high mortality rate. Antibiotics with or without surgical treatment are required for treatment. We present a case in which phlegmonous gastritis occurred during the diagnostic evaluation of early gastric cancer. The patient showed improvement after antibiotic treatment, but attempted endoscopic submucosal dissection failed because of submucosal pus. We immediately applied argon plasma coagulation since surgical resection was also considered a high-risk procedure because of the submucosal pus and multiple comorbidities. However, there was local recurrence two years later, and the patient underwent subtotal gastrectomy with lymph node dissection. Considering the risk of incomplete treatment immediately after recovery from phlegmonous gastritis and that recurrent disease can be more difficult to manage, delaying treatment and evaluation until after complete recovery of PG might be a better option in this particular clinical situation.
Anti-Bacterial Agents
;
Argon Plasma Coagulation
;
Bacterial Infections
;
Cellulitis*
;
Comorbidity
;
Gastrectomy
;
Gastritis*
;
Humans
;
Lymph Node Excision
;
Mortality
;
Recurrence
;
Stomach
;
Stomach Neoplasms*
;
Suppuration
6.Plasma endocan level and prognosis of immunoglobulin A nephropathy.
Yu Ho LEE ; Jin Sug KIM ; Se Yun KIM ; Yang Gyun KIM ; Ju Young MOON ; Kyung Hwan JEONG ; Tae Won LEE ; Chun Gyoo IHM ; Sang Ho LEE
Kidney Research and Clinical Practice 2016;35(3):152-159
BACKGROUND: Endocan, previously called endothelial cell–specific molecule-1, is a soluble proteoglycan that is secreted from vascular endothelial cells. Elevated plasma endocan levels were shown to be associated with poor cardiovascular outcomes in patients with chronic kidney disease (CKD). We investigated the clinical relevance of plasma and urine endocan levels in patients with immunoglobulin A nephropathy (IgAN). METHODS: Sixty-four patients with IgAN and 20 healthy controls were enrolled in this study. Plasma and urine endocan levels were measured. Clinical parameters, pathologic grades, and renal outcomes were compared among subgroups with different plasma and urine endocan levels. RESULTS: Both plasma and urine endocan levels were significantly higher in patients with IgAN than in controls. Elevated serum phosphorus and C-reactive protein were independent determinants for plasma endocan, and elevated C-reactive protein was also an independent determinant for urine endocan levels in multivariate analysis. Plasma endocan level was not significantly different across CKD stages, but patients with higher plasma endocan levels showed adverse renal outcome. Urine endocan levels were also elevated in patients with poor renal function. Cox proportional hazard models showed that high plasma endocan was an independent risk factor for CKD progression after adjusting for the well-known predictors of outcome in patients with IgAN. CONCLUSION: This study suggested that plasma endocan might be useful as a prognostic factor in patients with IgAN.
C-Reactive Protein
;
Endothelial Cells
;
Glomerulonephritis, IGA*
;
Humans
;
Immunoglobulin A*
;
Immunoglobulins*
;
Multivariate Analysis
;
Phosphorus
;
Plasma*
;
Prognosis*
;
Proportional Hazards Models
;
Proteoglycans
;
Renal Insufficiency, Chronic
;
Risk Factors
7.Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy.
Ji Hoon LEE ; Shin Yeong LEE ; Jin Sug KIM ; Da Rae KIM ; Su Woong JUNG ; Kyung Hwan JEONG ; Tae Won LEE ; Yoo Ho LEE ; Yang Gyun KIM ; Ju Young MOON ; Sang Ho LEE ; Chun Gyoo IHM
Kidney Research and Clinical Practice 2016;35(3):147-151
BACKGROUND: Immunoglobulin E (IgE) has traditionally been associated with anaphylaxis and atopic disease. Previous studies reported that serum IgE levels are elevated in nephrotic syndrome and suggested IgE levels as a prognostic indicator in glomerular diseases. The aim of this study was to explore the association between serum IgE levels and renal outcome in patients with immunoglobulin A nephropathy (IgAN). METHODS: We included 117 patients with biopsy-proven IgAN. Renal progression was defined if a patient meets one of these criteria: (1) a negative value of delta estimated glomerular filtration rate (mL/min/1.73 m²/mo) or (2) a rise in serum creatinine to an absolute level of ≥ 1.3 mg/dL (male) or 1.2 mg/dL (female). We defined delta changes in serum creatinine, estimated glomerular filtration rate, and proteinuria as a difference of values during the follow-up period. RESULTS: A total of 117 patients with IgAN were included. The serum IgE level was significantly high in the renal progressive group compared with the nonprogressive group. Sex and history of gross hematuria were significantly different between the high-IgE group and the low-IgE group. Regression analysis showed that a male sex, initial proteinuria, and change of proteinuria were significantly associated with serum IgE levels. CONCLUSION: The serum IgE level is potentially associated with disease progression and pathogenesis of IgAN.
Anaphylaxis
;
Creatinine
;
Disease Progression
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Glomerulonephritis
;
Glomerulonephritis, IGA*
;
Hematuria
;
Humans
;
Immunoglobulin A*
;
Immunoglobulin E*
;
Immunoglobulins*
;
Male
;
Nephrotic Syndrome
;
Proteinuria
8.Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension.
Yu Ho LEE ; Yang Gyun KIM ; Ju Young MOON ; Jin Sug KIM ; Kyung Hwan JEONG ; Tae Won LEE ; Chun Gyoo IHM ; Sang Ho LEE
Electrolytes & Blood Pressure 2016;14(2):21-26
One of the major pathophysiological features of primary hypertension is an inappropriate activation of the sympathetic nervous system, which is mediated by excessive synthesis and secretion of catecholamine into the blood. Tyrosine hydroxylase (TH), a rate-limiting enzyme in the synthesis of catecholamine, has been highlighted because genetic variations of TH could alter the activity of the sympathetic nervous system activity and subsequently contribute to the pathogenesis of hypertension. Here, we discuss the role of TH as a regulator of sympathetic activity and review several studies that investigated the relationship between genetic variations of TH and hypertension.
Genetic Variation*
;
Hypertension*
;
Polymorphism, Single Nucleotide
;
Sympathetic Nervous System
;
Tyrosine 3-Monooxygenase*
;
Tyrosine*
9.Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications.
Hyeon Woo LIM ; Tae Hyun KIM ; Il Ju CHOI ; Chan Gyoo KIM ; Jong Yeul LEE ; Soo Jeong CHO ; Hyeon Seok EOM ; Sung Ho MOON ; Dae Yong KIM
Radiation Oncology Journal 2016;34(3):193-201
PURPOSE: To assess the clinical outcomes of radiotherapy (RT) using two-dimensional (2D) and three-dimensional conformal RT (3D-CRT) for patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma to evaluate the effectiveness of involved field RT with moderate-dose and to evaluate the benefit of 3D-CRT comparing with 2D-RT. MATERIALS AND METHODS: Between July 2003 and March 2015, 33 patients with stage IE and IIE gastric MALT lymphoma received RT were analyzed. Of 33 patients, 17 patients (51.5%) were Helicobacter pylori (HP) negative and 16 patients (48.5%) were HP positive but refractory to HP eradication (HPE). The 2D-RT (n = 14) and 3D-CRT (n = 19) were performed and total dose was 30.6 Gy/17 fractions. Of 11 patients who RT planning data were available, dose-volumetric parameters between 2D-RT and 3D-CRT plans was compared. RESULTS: All patients reached complete remission (CR) eventually and median time to CR was 3 months (range, 1 to 15 months). No local relapse occurred and one patient died with second primary malignancy. Tumor response, survival, and toxicity were not significantly different between 2D-RT and 3D-CRT (p > 0.05, each). In analysis for dose-volumetric parameters, D(max) and CI for PTV were significantly lower in 3D-CRT plans than 2D-RT plans (p < 0.05, each) and D(mean) and V₁₅ for right kidney and D(mean) for left kidney were significantly lower in 3D-CRT than 2D-RT (p < 0.05, each). CONCLUSION: Our data suggested that involved field RT with moderate-dose for gastric MALT lymphoma could be promising and 3D-CRT could be considered to improve the target coverage and reduce radiation dose to the both kidneys.
Helicobacter pylori
;
Humans
;
Kidney
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell, Marginal Zone*
;
Radiotherapy
;
Recurrence
;
Stomach
10.A case of Ramsay Hunt syndrome diagnosed after kidney transplantation.
Yoo Min PARK ; Da Rae KIM ; Ji Yoon PARK ; Seul Ki KIM ; Se Yun KIM ; Jin Sug KIM ; Yu Ho LEE ; Yang Gyun KIM ; Kyung Hwan JEONG ; Ju Young MOON ; Sang Ho LEE ; Chun Gyoo IHM ; Tae Won LEE
Kidney Research and Clinical Practice 2015;34(4):241-244
We report the first case of Ramsay Hunt syndrome (RHS) diagnosed after kidney transplantation in Korea. RHS is a disease caused by latent varicella-zoster characterized to involve geniculate ganglion of the seventh cranial nerve. Patients who have undergone kidney transplantation can be easily affected by viral infections because of their immune-compromised status. A 35-year-old man with hypertensive end-stage renal disease underwent kidney transplantation. Two months after surgery, the recipient was diagnosed with RHS and treated with antivirals and steroids. However, after using the antiviral agents for the recommended duration, facial paralysis occurred as a new presentation and he required further treatment. Otalgia and periauricular vesicles improved, but the facial palsy remained.
Adult
;
Antiviral Agents
;
Earache
;
Facial Nerve
;
Facial Paralysis
;
Geniculate Ganglion
;
Herpes Zoster Oticus*
;
Herpesvirus 3, Human
;
Humans
;
Kidney Failure, Chronic
;
Kidney Transplantation*
;
Kidney*
;
Korea
;
Steroids

Result Analysis
Print
Save
E-mail